Is Rad51D heterozygous mutation a contraindication to postmastectomy radiation?
1
1 Answers
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network
BRCA1/2, PALPB2, CHEK2, and RAD50/51 mutations should not affect radiation therapy https://www.redjournal.org/article/S0360-3016(19)33530-8/fulltext